Tony Gonsolin hasn't thrown a full, healthy MLB season since 2022, but Kansas City is willing to find out if that guy is still in there. The Royals officially announced the signing on August 13, and the terms spread fast across the baseball internet.
It's a major league deal, not a minor league flier, which tells you the Royals see real upside here even with the medical file attached. Gonsolin is coming off an internal brace and flexor repair procedure last August, his second major elbow surgery in 3 years after 2023 Tommy John surgery wiped out most of that season too. He's already been placed on the 15-day injured list as part of the deal, which lines up with a recovery timeline that reportedly runs 8-10 months.
That injury history is exactly why this is framed as a 2027 audition and not a 2026 fix. Gonsolin was outrighted off the Dodgers' 40-man roster in November and elected free agency after a lost season, closing the book on a run that included 572 2/3 innings across 59 appearances from 2019-2022 in Los Angeles. Kansas City's front office is reportedly staring down a rotation gutted by Tommy John surgeries among its own prospect arms, and a healthy 2027 version of Gonsolin would be a cheap way to patch that hole.
There's real risk in the bet, obviously. Gonsolin turns 32 this year and hasn't strung together a clean, full season since his best Dodgers run, when he was a mid-rotation arm who overperformed his peripherals thanks to a friendly BABIP and a strong strand rate. Still, a 24.8% strikeout rate in that stretch says there's legitimate stuff underneath the medical charts, which is presumably why Kansas City felt comfortable guaranteeing a big league roster spot instead of stashing him in the minors.
For now, Gonsolin's job is just to get healthy. If he does, the Royals have themselves a low-cost rotation piece walking into 2027 with something to prove — and if he doesn't, they've lost very little for finding out.